Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated (original) (raw)
Related papers
Anxiety and Depression in Patients with Rheumatic diseases
2013
The state of psycho-emotional sphere of patients is off paramount importance for many diseases of internal organs. Recent years, particular attention is drawn to the study of this problem. A study of anxiety and depression in patients with rheumatic diseases was conducted on the basis of Outpatients Department in 137 patients with rheumatic diseases; among them were 79female and 58 male, aged 18 to 77 years. Our research showed that respondents of patients with rheumatic diseases depression was noted in 57%, anxiety – in 68%, while anxiety and depression in 45% of patients. Given the role of anxiety and depression during the rheumatic diseases, in its burdens should be paid special attention to physicians rheumatologists on this fact, what remains in addition to the attention of doctors.
Anxiety and depression in primary care patients suffering of rheumatoid diseases
Psychiatriki, 2020
heumatic diseases are chronic debilitating conditions with a known association with anxiety and depression. Individuals with rheumatic diseases experience more psychological distress as these conditions mostly follows a painful, progressively disabling course. The aim of this study was to assess the levels and explore factors associated with anxiety and depression experienced by Greek patients with rheumatic diseases. The sample consisted of 108 patients with rheumatic diseases who visited a rheumatology outpatient clinic. Data collection was conducted using a questionnaire which included patients' characteristics and the Zung Self-Rating Depression Scale (SDS) and Anxiety Scale (SAS). Of the 108 patients in the current study, 44.6% and 41.5% were assessed with depression and anxiety, respectively. Among patients exhibiting depression, 13% had severe depression, with the rest having moderate (12%) and mild (19.6%) severity of depression. Among patients exhibiting anxiety, the majority (20.2%) exhibited mild anxiety, whereas 17% of patients exhibited moderate and 4.3% severe anxiety. Higher levels of depression were experienced by those who experienced severe pain (p=0.001), those who were relapsed (p=0.008), those who had quitted their job due to health limitations (p=0.021), those who had the experience of a miscarriage (p=0.021) and those who used antidepressant or antianxiety medication (p<0.001). Higher levels of anxiety were experienced by female (p=0.011), the unemployed (p=0.047), those who experienced severe pain (p<0.001), those who were relapsed (p=0.015) and those who used antidepressant or antianxiety medication (p<0.001). Individuals with rheumatic diseases should be monitored for accompanying anxiety or depression during follow-up. Given their high prevalence, their profound impact on quality of life, and the range of effective treatments available, health care providers should be encouraged to screen all patients for both anxiety and depression. It is important to assess patients' characteristics when implementing strategies to confront with psychiatric disorders in this vulnerable population group.
Anxiety, Depression and Stress in Patients with Rheumatoid Arthritis
Procedia - Social and Behavioral Sciences, 2016
Problem Statement: Rheumatic diseases carries a high physical, psychological and social impact, with relevant multi-dimensional assessment of psychosocial functioning of these rheumatic patients, reasons for carrying out the present study. Research Questions: What is the prevalence of anxiety, depression and stress in patients with rheumatoid arthritis? Purpose of the Study: This aimed to identify the prevalence of anxiety, depression and stress in people with rheumatoid arthritis These have in our population worse quality of life indicators, when compared with the general population. Research Methods: The study observational was conducted with 80 participants, 82.5% were female, aged between 21 and 80 years, with an average of 58.16 years.
Anxiety and depression in rheumatologic diseases: the relevance of diagnosis and management
Reumatismo, 2014
The high prevalence of emotional disorders (anxiety, chronic stress, mood depression) in patients with pain during rheumatologic diseases (particularly fibromyalgia) is closely related to the common pathogenic mechanisms concerning emotions and pain. Therefore a prompt identification of any psychic component of pain, also by means of specific tools, is a must, because it can require an adjustment of the therapeutic approach by combining both an analgesic treatment and antidepressants and/or psychotherapeutic strategies.
Psychological interventions for patients with rheumatic diseases and anxiety or depression
Best Practice & Research Clinical Rheumatology, 2012
R. Geenen), Stanton.Newman.1@city.ac.uk (S. Newman), E.R.Bossema@uu.nl (E.R. Bossema), J.Vriezekolk@maartenskliniek.nl (J.E. Vriezekolk), P.A.Boelen@uu.nl (P.A. Boelen). 1 Tel.: þ44 2070405829. 2 Tel.: þ31 30 253 4431; fax: þ31 30 253 4718. 3 Tel.: þ31 24 365 9367; fax: þ31 24 365 9154. 4 Tel.: þ31 30 253 3021; fax: þ31 30 253 4718.
Is anxiety a more common disorder than depression in rheumatoid arthritis?
Joint Bone Spine, 2002
Objective. As most of the previous studies were done to study depressive disorders and /or symptoms in patients with rheumatoid arthritis, this study was performed to investigate whether anxiety disorder is as common as depressive disorder in these patients and to look for the socio-demographic as well as the clinical characteristics of the patients developing these disorders. Methods. A detailed physical assessment of 80 patients with rheumatoid arthritis was performed. Also psychiatric assessment was done using Research Diagnostic Criteria for the International Classification of Diseases-10 (ICD-10). In addition, patients answered a Health Assessment Questionnaire (HAQ) to assess their functional capacity. Results. Depression was diagnosed in 66.2% of the total sample while anxiety was diagnosed in 70%. Functional disability, social stress and morning stiffness were the factors highly associated with depression. Using multiple regression analysis, anxiety was highly associated with depression as well as Ritchie articular index. Conclusion. Psychiatric illness is a relatively common disorder in patients with RA, with a frequency higher than that of other general medical conditions. Anxiety is a more common disorder than depression. The first step in correct management is recognition of anxiety and depression so that appropriate treatment can be tried. Particular attention has to be paid to social stress and lack of social support.
2017
Background: Psychiatric disorders occur in a considerable proportion of patients with rheumatoid arthritis (RA), often reflecting the difficulties of these patients in coping with a chronic debilitating disorder. Aim of the study: We aimed to study Evaluation of depression and its correlation with anxiety symptoms, quality of life index and duration of disease in patients with rheumatoid arthritis. Methods: Patients were defined as having RA and depression when there was at least one documented diagnosis identified by the International Classification of Diseases-10 (ICD-10) from the medical records. The proportion of depression was compared between RA patients and controls. A logistic regression model was used to estimate the association between RA and depression, anxiety disorder, quality of life index and duration of disease in a multivariate analysis adjusted for age, gender and socioeconomic status. Results: The study included 120 patients with RA and 40 people without mental and somatic pathology. Depression in RA patients included mild depressive disorders (GA-37.74%, GB-4.48%), anxiety-depressive disorders (GA-28.30% GB-41.79%), depressive-hypochondriac disorders (GA-3.77%, GB-20.90%). In multivariate analysis, RA was found to be independently associated with depression and anxiety. Conclusion: Our study confirms the higher proportion of depression in RA patients: especially young women with average socioeconomic status (mild depressive disorders); old women with low socioeconomic status (depressive-hypochondriac disorders). The impairment of quality of life is markedly in patient with depressive-hypochondriac disorders. Physicians should be aware of such findings and, therefore, apply proper screening strategies.
BMC musculoskeletal disorders, 2016
This study aimed to investigate the impact of depression and anxiety scores on disease activity at 1-year follow-up in people with Rheumatoid Arthritis (RA). The Hospital Anxiety Depression Scale (HADS) was used to measure depression and anxiety in a cross-section of RA patients. The primary outcome of interest was disease activity (DAS28), measured one-year after baseline assessment. Secondary outcomes were: tender joint count, swollen joint count, erythrocyte sedimentation rate and patient global assessment, also measured one-year after baseline assessment. We also examined the impact of baseline depression and anxiety on odds of reaching clinical remission at 1-year follow-up. In total, 56 RA patients were eligible for inclusion in this analysis. Before adjusting for key demographic and disease variables, increased baseline depression and anxiety were associated with increased disease activity at one-year follow-up, although this was not sustained after adjusting for baseline dis...
BMC Psychiatry, 2012
Background: While it is recognised that depression is prevalent in Rheumatoid Arthritis (RA), recent studies have also highlighted significant levels of anxiety in RA patients. This study compared two commonly used scales, the Depression Anxiety and Stress Scale (DASS) and the Hospital Anxiety and Depression Scale (HADS), in relation to their measurement range and cut points to consider the relative prevalence of both constructs, and if prevalence rates may be due to scale-specific case definition. Methods: Patients meeting the criteria for RA were recruited in Leeds, UK and Sydney, Australia and asked to complete a survey that included both scales. The data was analysed using the Rasch measurement model. Results: A total of 169 RA patients were assessed, with a repeat subsample, resulting in 323 cases for analysis. Both scales met Rasch model expectations. Using the 'possible+probable' cut point from the HADS, 58.3% had neither anxiety nor depression; 13.5% had anxiety only; 6.4% depression only and 21.8% had both 'possible+probable' anxiety and depression. Cut points for depression were comparable across the two scales while a lower cut point for anxiety in the DASS was required to equate prevalence. Conclusions: This study provides further support for high prevalence of depression and anxiety in RA. It also shows that while these two scales provide a good indication of possible depression and anxiety, the estimates of prevalence so derived could vary, particularly for anxiety. These findings are discussed in terms of comparisons across studies and selection of scales for clinical use.